A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication

Journal of Controlled Release

Volumn 171, Issue 2, 2013, Pages 104-112

  Hossen, Md Nazir ^a   Kajimoto, Kazuaki ^a   Akita, Hidetaka ^a   Hyodo, Mamoru ^a   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Adipotide; Antiangiogenesis; Diet induced obesity; Ectopic fat; Metabolic syndrome; Nanoparticle targeted proapoptotic peptide

Indexed keywords

BIOMOLECULES; BODY FLUIDS; DEPOSITION; ENDOTHELIAL CELLS; METABOLISM; NANOPARTICLES; PEPTIDES;

ADIPOTIDE; ANTIANGIOGENESIS; CYTOPLASMIC DELIVERY; DIET-INDUCED OBESITY; ENHANCED PERMEABILITY AND RETENTION EFFECT; METABOLIC SYNDROMES; TARGETED NANOPARTICLE; TARGETED THERAPEUTICS;

NUTRITION;

ADIPONECTIN; ADIPOTIDE; LEPTIN; NANOPARTICLE; PEPTIDE; PROHIBITIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ADIPOSE TISSUE CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG TARGETING; ENDOSOME; ENDOTHELIUM CELL; HORMONE BLOOD LEVEL; LIPID STORAGE; LIPOLYSIS; LOW DRUG DOSE; LYSOSOME; MACROPHAGE; MALE; MOUSE; NANOENCAPSULATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION;

ADIPOTIDE; ANTIANGIOGENESIS; DIET-INDUCED OBESITY; ECTOPIC FAT; METABOLIC SYNDROME; NANOPARTICLE-TARGETED PROAPOPTOTIC PEPTIDE;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; ANTI-OBESITY AGENTS; BODY WEIGHT; DIET, HIGH-FAT; LEPTIN; LIVER; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NANOPARTICLES; OBESITY; PEPTIDES; PEPTIDOMIMETICS; REPRESSOR PROTEINS;

EID: 84881183949     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.07.013     Document Type: Article

References (27)

1. A. Lettner, M. Roden, Ectopic fat and insulin resistance, Curr. Diabetes Rep. 8 (3) (2008) 185-191.
2. E. Fabbrini, F. Magkos, B.S. Mohammed, T. Pietka, N.A. Abumrad, B.W. Patterson, et al., Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity, Proc. Natl. Acad. Sci. U. S. A. 106 (36) (2009) 15430-15435.
3. M. Krssak, K. Falk Petersen, A. Dresner, L DiPietro, S.M. Vogel, D.L. Rothman, et al., Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study, Diabetologia 42 (1) (1999) 113-116. (Pubitemid 29039748)
4. A. Bouloumie, K. Lolmede, C. Sengenes, J. Galitzky, M Lafontan, Angiogenesis in adipose tissue, Ann. Endocrinol. (Paris) 63 (2 Pt 1) (2002) 91-95. (Pubitemid 34538250)
5. S. Nishimura, I. Manabe, M. Nagasaki, Y. Hosoya, H. Yamashita, H. Fujita, et al, Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels, Diabetes 56 (6) (2007) 1517-1526. (Pubitemid 46842598)
6. S. Nishimura, I. Manabe, M. Nagasaki, K. Eto, H. Yamashita, M. Ohsugi, et al, CD8 + effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity, Nat Med. 15 (8) (2009) 914-920.
7. M.G. Kolonin, P.K. Saha, L Chan, R. Pasqualini, W. Arap, Reversal of obesity by targeted ablation of adipose tissue, Nat Med. 10 (6) (2004) 625-632. (Pubitemid 38796854)
8. K.F. Barnhart, D.R. Christianson, P.W. Hanley, W.H. Driessen, B.J. Bernacky, W.B. Baze, et al., A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys, Sci. Transl. Med. 3 (108) (2011) 108ra112.
9. M.N. Hossen, K. Kajimoto, H. Akita, M. Hyodo, H. Harashima, Vascular-targeted nanotherapy for obesity: unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery, J. Control. Release 163 (2) (2012) 101-110.
10. Y. Matsumura, H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumortropic accumulation of proteins and the antitumor agent smancs, Cancer Res. 46 (12 Pt 1) (1986) 6387-6392. (Pubitemid 17221789)
11. M.N. Hossen, K. Kajimoto, H. Akita, M Hyodo, T. Ishitsuka, H. Harashima, Therapeutic assessment of cytochrome c for the prevention of obesity through endothelial cell-targeted nanoparticulate system, Mol. Ther. (January 2013), http://dx.doi.org/10.1038/mt2012.256, (Online).
12. M.N. Hossen, K. Kajimoto, H. Akita, M. Hyodo, T. Ishitsuka, H. Harashima, Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue, J. Control. Release 147 (2) (2010) 261-268.
13. K. Kajimoto, M.N. Hossen, K. Hida, N. Ohga, H. Akita, M. Hyodo, et al., Isolation and culture of microvascular endothelial cells from murine inguinal and epididymal adipose tissues, J. Immunol. Methods 357 (1-2) (2010) 43-50.
14. R.V. Considine, M.K. Sinha, M.L. Heiman, A. Kriauciunas, T.W. Stephens, M.R. Nyce, et al, Serum immunoreactive leptin concentrations in normal-weight and obese humans, N. Engl. J. Med. 334 (5) (1996) 292-295. (Pubitemid 26033933)
15. E. Hu, P. Liang, B.M. Spiegelman, AdipoQis a novel adipose-specific gene dysregulated in obesity, J. Biol. Chem. 271 (18) (1996) 10697-10703. (Pubitemid 26145805)
16. C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley, et al, Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia, J. Clin. Endocrinol. Metab. 86 (5) (2001) 1930-1935. (Pubitemid 32472900)
17. E.W. Kraegen, P.W. Clark, A.B. Jenkins, E.A. Daley, D.J. Chisholm, LH. Storlien, Development of muscle insulin resistance after liver insulin resistance in high-fat fed rats, Diabetes 40 (11) (1991) 1397-1403.
18. M.A. Rupnick, D. Panigrahy, C.Y. Zhang, S.M. Dallabrida, B.B. Lowell, R. Langer, M.J. Folkman, et al, Adipose tissue mass can be regulated through the vasculature, Proc. Natl. Acad. Sci. U. S. A. 99 (16) (2002) 10730-10735.
19. A. Ejaz, D. Wu, P. Kwan, M. Meydani, Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice, J. Nutr. 139 (5) (2009) 919-925.
20. H.R. Lijnen, E. Maquoi, L.B. Hansen, B. Van Hoef, L. Frederix, D. Collen, Matrix metal-loproteinase inhibition impairs adipose tissue development in mice, Arterioscler. Thromb. Vasc. Biol. 22 (3) (2002) 374-379. (Pubitemid 34218741)
21. E. Brakenhielm, R. Cao, B. Gao, B. Angelin, B. Cannon, P. Parini, Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice, Circ. Res. 94 (12) (2004) 1579-1588. (Pubitemid 38856965)
22. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, A.W. Ferrante, Obesity is associated with macrophage accumulation inadipose tissue,J. Clin. Invest. 112 (12) (2003) 1796-1808.
23. Y. Cao, Angiogenesis modulates adipogenesis and obesity, J. Clin. Invest. 117 (9) (2007) 2362-2368. (Pubitemid 47494333)
24. Y. Cao, Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases, Nat. Rev. Drug Discov. 9 (2) (2010) 107-115.
25. T. Yamauchi, J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, et al., Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase, Nat. Med. 8 (11) (2002) 1288-1295. (Pubitemid 35373562)
26. P. Dan, M.J. Karp, H. Seungpyo, C.F. Omid, M. Rimona, L. Robert, Nanocarriers as an emerging platform for cancer therapy, Nat. Nanotechnol. 2 (12) (2007) 751-760.
27. X. Montet, M. Funovics, K. Montet-Abou, R. Weissleder, L. Josephson, Multivalent effects of RGD peptides obtained by nanoparticle display, J. Med. Chem. 49 (20) (2006) 6087-6093. (Pubitemid 44484952)